NCT02155504View on ClinicalTrials.gov

A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP3700 in Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Healthy VolunteersPharmacokinetics of ASP3700
Interventions
DRUG

ASP3700

oral

DRUG

itraconazole

oral

DRUG

Placebo

oral

Trial Locations (1)

HA1 3UJ

Parexel Early Phase Clinical Unit, Harrow

All Listed Sponsors
lead

Astellas Pharma Europe B.V.

INDUSTRY

NCT02155504 - A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP3700 in Healthy Male Subjects | Biotech Hunter | Biotech Hunter